Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Capital Expenditures: 2015-2024

Historic Capital Expenditures for Kura Oncology (KURA) over the last 6 years, with Dec 2024 value amounting to $472,000.

  • Kura Oncology's Capital Expenditures was N/A to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year change of. This contributed to the annual value of $472,000 for FY2024, which is 180.95% up from last year.
  • Per Kura Oncology's latest filing, its Capital Expenditures stood at $472,000 for FY2024, which was up 180.95% from $168,000 recorded in FY2023.
  • Kura Oncology's 5-year Capital Expenditures high stood at $2.2 million for FY2020, and its period low was $168,000 during FY2023.
  • Its 3-year average for Capital Expenditures is $422,000, with a median of $472,000 in 2024.
  • In the last 5 years, Kura Oncology's Capital Expenditures tumbled by 73.16% in 2023 and then skyrocketed by 180.95% in 2024.
  • Yearly analysis of 5 years shows Kura Oncology's Capital Expenditures stood at $2.2 million in 2020, then crashed by 47.17% to $1.1 million in 2021, then tumbled by 45.42% to $626,000 in 2022, then crashed by 73.16% to $168,000 in 2023, then spiked by 180.95% to $472,000 in 2024.